Stockreport

UPDATE 4-Regeneron, Sanofi arthritis drug may only help critical coronavirus patients -study [Reuters]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Regeneron, Sanofi arthritis drug may only help critical coronavirus patients: study (Reuters) - Results of a study of Regeneron Pharmaceuticals Inc and Sanofi SA’s rheum [Read more]